Clinigen Group Plc (CLINC)

London
652.50
-7.00(-1.06%)
  • Volume:
    172,870
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    649.00 - 667.00

CLINC Overview

Prev. Close
659.5
Day's Range
649-667
Revenue
781.7M
Open
667
52 wk Range
554-891.79
EPS
0.29
Volume
172,870
Market Cap
867.98M
Dividend (Yield)
7.61
(1.15%)
Average Volume (3m)
581,700
P/E Ratio
22.13
Beta
1.46
1-Year Change
14.47%
Shares Outstanding
133,023,219
Next Earnings Date
21 Feb 2022
What is your sentiment on Clinigen Group Plc?
or
Market is currently closed. Voting is open during market hours.

Clinigen Group Plc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyBuySell
Technical IndicatorsStrong BuyNeutralSellStrong BuyStrong Sell
SummaryStrong BuyBuyNeutralStrong BuyStrong Sell

Clinigen Group Plc Company Profile

Clinigen Group Plc Company Profile

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Read More
  • An ideal target for takeover
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.